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Summary. Cyclic monkeys were deprived of FSH for specific periods on different days
of the follicular phase by injecting them with minimal doses of an FSH antiserum
characterized for specificity and bioneutralizing ability. The effect of the antiserum on
follicular maturation was assessed by determining (a) serum oestrogen concentrations
through the midcycle period, (b) serum progesterone concentrations as an index of
ovulation and luteal function, (c) laparoscopic examination of the surface of the ovary
when necessary, and (d) overall cycle length. While antiserum injection on Day 5 of the
cycle caused delay in the oestrogen surge from Days 9 to 11, injection on Day 6 led to
the occurrence of two oestrogen surges, on Days 9 and 14. Laparoscopic examination
showed that the earlier follicle had disappeared and a new follicle had appeared by Day
14. Antiserum injection on Day 7 of the cycle arrested further growth of the maturing
follicle, but a new follicle appeared 9 days later, as indicated by a surge of oestrogen on
Day 16. Injection of antiserum beyond Day 7 had no effect on follicular development,
ovulation and luteal function. These observations suggest that the mature follicle
becomes relatively independent of FSH support about 48 h before ovulation and this
event could be a marker for follicular dominance.
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Introduction
Follicular maturation in the primate is unique in that, during any given cycle, a single follicle
amongst a cohort achieves development into a large mature follicle which subsequently ovulâtes
and forms a corpus luteum. Although it is well known that FSH and LH are required for promot¬
ing preovulatory growth of the follicle in most species including the primate (Knobil et al, 1959;
Gemzell, 1962; Rabinowitz et al, 1972; Moudgal et al, 1974), information on the precise role these
two hormones play in the regulation of follicular growth and differentiation is meagre. The
methods used thus far to investigate the problem, such as studying the effect of cauterizing the
dominant follicle of cycle and investigating its effect on ovarian function in the ensuing cycle
(Hodgen, 1982), studying the effect of partial suppression of FSH with whole pig follicular fluid on
cycle events (Channing et al, 1979, 1981; diZerega et al, 1981) and cell culture of granulosa cells
from follicles of different sizes (Channing et al, 1982), have all provided only circumstantial
evidences for the role of FSH/LH in follicular maturation. The use of FSH antibodies for under¬
standing the FSH requirements for follicular maturation in rodents (Sheela Rani & Moudgal, 1977,
1978, 1979, 1983) and rabbits (Vani, 1986), and for testicular function in monkeys (Murty et al,
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1979; Moudgal, 1981) suggested that a similar approach could be used to study the role of FSH in
cyclic follicular maturation of the primate.
Materials and Methods
Animals. Healthy adult female bonnet monkeys (Macaca radiata) of proven fertility were used. The details of care,
maintenance and feeding were as previously described (Mukku & Moudgal, 1979; Ravindranath & Moudgal, 1987).
The animals used in the present series of experiments were 9-12 years of age and weighed approximately 5 kg each.
Antiserum. An antiserum to sheep FSH raised in a donor male bonnet monkey was used. The method of immuniz¬
ation and characterization of the antiserum have been described elsewhere (Murthy & Moudgal, 1987; Ravindranath,
1988). The antiserum, devoid of any contaminating LH antibodies, was tested for its ability to bind and neutralize
heterologous primate FSH (human and cynomolgus FSH) before it was used to neutralize circulating concentrations
of monkey FSH.
General methodology. The minimal effective dose of FSH antiserum capable of neutralizing circulating concen¬
trations of FSH for approximately 24 h was determined by injecting a group of monkeys with different doses of
antiserum on Day 1 of the cycle and analysing serum samples at specific times thereafter for the presence of antibodies
capable of binding I25I-labelled sheep and human FSH. The ovine FSH used for radioiodination was purified in the
laboratory (purity, 99-9%). Human FSH (hFSH-Sl 1-108B) was obtained from Dr M. R. Sairam (Montreal, Canada).
Incubation of the labelled hormone with 100 pi of neat serum in each case in triplicate was done overnight at room
temperature (26°C). The antibody-bound label was precipitated with polyethylene glycol (mol. wt 6000) at 10-12%
final concentration. The non-specific binding of 125I-labelled hormone, determined using the same volume of a pre-
injection serum sample from the same monkey, was deducted from the value for the experimental samples to obtain
net binding. The binding ability of the labelled hormone with an excess of the characterized antiserum ranged between
55 and 65% for sheep FSH and 45 and 55% for human FSH. The specific activity of the label ranged from 4-5 to
5  10* c.p.m./ng (45-50 pCi/pg) for ovine FSH and 3 to 3-5  IO4 c.p.m./ng (30-35 pCi/pg) for human FSH. Data
are expressed assuming maximum binding to represent 100% binding.
All injections of the antiserum were done at 10:00 h by the i.p. route. Blood samples were taken using Vacutainer
tubes from unanaesthetized monkeys. Serum was separated within 12 h of collection and stored at
—
20°C until
further processing.
Hormone assays. Oestradiol and progesterone in the serum samples were estimated by specific radioimmunoassays
standardized in the laboratory (Prahalada et al, 1975). The oestradiol antiserum used in the assay cross-reacted with
oestrone (10%) and oestriol (< 1%). The inter- and intra-assay coefficients of variation were 15 and 12-5% respect¬
ively. The progesterone antiserum cross-reacted with 17a-hydroxyprogesterone (3%) and 20a-dihydroprogesterone(5%). The inter- and intra-assay coefficient of variations were 9% and 8% respectively. The sensitivity of the assay for
progesterone was 001 ng and for oestradiol 002 ng.
Results
Characteristics of the FSH antiserum used in the current study
The ability of the antiserum to bind ovine and human FSH as well as ovine and human LH
before and after affinity purification using an LH sepharose column (Murthy & Moudgal 1987) is
shown in Table 1. While LH antibodies were completely removed by this process, the specific FSH
antibody concentration remained unaltered. The binding affinity (Kz) and capacity for hFSH
determined using Scatchard analysis was 0-3  1010 M" ' and 43-8 µg/ml respectively (Vani, 1986).
The ability of the antiserum to bioneutralize human FSH (used here as a representative of
primate FSH) was determined using an in-vitro rat granulosa cell system standardized in the
laboratory. Human FSH stimulated progesterone production in these cells (50 000 cells/tube/4 h) in
a dose-dependent manner (tested over a range of 10-100 ng/tube), 50 ng hFSH producing an
optimal response. Preincubating 50 ng hFSH with the antiserum resulted in an inhibition of the
hormone response and this was dose-dependent (range 28-77%) and was statistically significant
(P < 005; Fig. 1). The bioneutralizing capacity of the antiserum calculated from the above data
was 8 µg hFSH/ml and was markedly lower than the overall binding capacity as determined by
Scatchard analysis. This is not surprising as only a portion of the total polyclonal antibody pool
could be of the bioneutralizing type, namely that capable of preventing hFSH from binding to
Table 1. Relative ability of FSH antiserum to bind ovine and
human FSH and LH before and after affinity purification
% Specific binding*
125I-labelled
hormone
Dilution of
antiserum
Before
Sepharose-LH
treatment
After
Sepharose-LH
treatment
oFSH
hFSH
oLH
hLH
10
10000
20 000
10
100
10
58
38
25
48
60
32
47
28
26
41
12
0
*The antiserum at the specified dilutions was incubated with labelled
hormones at room temperature overnight and the antigen-antibody
complex formed was precipitated using polyethylene glycol at a final
concentration of 10-12%. The non-specific binding was determined by
incubating the labelled hormones with the buffer or normal monkey
serum and this was deducted to yield specific binding.
the receptor before evoking a response. The ability of the antiserum to bioneutralize non-human
primate FSH was assessed by (a) determining the capacity of the antibody to prevent cynomolgus
monkey FSH (kindly provided by Dr G. Bialy, NICHD, Bethesda, MD, USA) binding to FSH
receptor in an appropriate radio-receptor assay (100 µ of 1:500 diluted antiserum bound ~30ng
hFSH compared to 50 ng of a relatively cruder monkey FSH) and (b) demonstrating that binding
of 125I-labelled hFSH to the antibody can be blocked if serum from a castrated or normal bonnet
monkey is used. These studies suggested that, in the absence of purified bonnet monkey FSH,
human FSH could be used to assess the binding capacity of the FSH antiserum.
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Fig. 1. Bioneutralizing activity of FSH antiserum (No. 603) under in-vitro conditions using rat
granulosa cells. A- , Basal progesterone production; O-O, progesterone production
with 50 ng hFSH/tube in the presence of different doses of normal monkey serum; ·-·.
progesterone production with 50 ng hFSH/tube in the presence ofdifferent doses of antiserum.
Values are mean + s.d. (n = 6).
Determination of the in-vivo binding ability of the antiserum injected as a function ofdose and time
Cyclic female monkeys were treated i.p. on Day 1 of the cycle with 4, 1 or 0-2 ml of the charac¬
terized antiserum and the serum samples collected at specific times thereafter were analysed for the
presence of antibodies to ovine and human FSH. It is evident from Fig. 2 that antibodies capable of
binding hFSH disappeared at a much faster rate than that for antibodies directed against other
epitopes specific to oFSH. This is also a function of the dose of antiserum injected. The observation
that antibodies cross-reacting with hFSH disappeared rapidly could be a reflection of its ability to
bind endogenous monkey FSH. The times taken to achieve 50% binding with 125I-labelled ovine
FSH after injection of different volumes of antiserum (4, 1 and 0-2 ml) were up to 50, 45 and 15
days respectively. For the same volumes of antiserum, the times taken to achieve 50% binding of
125I-labelled human FSH were 22, 16 and 7-5 days respectively.
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Fig. 2. Percentage binding of labelled hormone to antibodies in the circulation in monkeys
injected with different doses of antiserum as a function of time. See text for details of method¬
ology: the nos indicate individual monkeys, (a, c, e) Represent binding to 125I-labelled sheep
FSH and (b, d, f) represent binding to 125I-labelled human FSH. (a, b) Monkeys injected(arrow) with 4 ml antiserum on Day 1 of the cycle; (c, d) monkey injected (arrow) with 1 ml
antiserum on Day 1 of the cycle; (e, f ) Monkeys injected (arrow) with 0-2 ml antiserum on Day
1 of the cycle.
Ability of the antibody to disrupt ovarian function:
In an initial study different doses of antiserum were injected on Day 1 of the cycle. The effect on
ovarian function was assessed by monitoring serum oestrogen and progesterone concentrations as
well as noting the time taken for menses to recur. It is evident from Fig. 3 that cycle length was
extended because there was arrest of the follicular maturation process.
Follicular maturation appeared to be reinitiated once the antibody titre (that fraction capable of
binding 125I-labelled hFSH) fell below 20%. The gradual increase in serum oestrogen values reach¬
ing a surge by Day 9 of cycle is an index of normal follicular growth and function (Ravindranath &
Moudgal, 1987). Depending on the initial dose of antiserum injected, the appearance of the oestro¬
gen surge was postponed. When the dose of antiserum was 40 ml, 20% binding to labelled hFSH
was recorded on Day 26 and the oestrogen surge occurred 9 days later in these animals, i.e. around
Day 35 of the cycle. Similarly, the monkeys receiving 10 ml and 0-2 ml of antiserum exhibited 20%
binding to labelled hFSH on Days 19 and 8 respectively. Correspondingly, the oestrogen surge was
observed in these groups of monkeys around Day 28 and Day 16 respectively. The follicle that
matured after the disappearance of the antibody underwent normal ovulation and luteinization as
indicated by normal progesterone patterns (Fig. 3; Table 2).
Since we were interested in arriving at a dose of antiserum which would be effective for no more
than 24 h, female monkeys were injected with 100 µ or 25 µ antiserum on Day 7 of the cycle. While
25 µ antiserum lasted for slightly longer than 24 h (computed on 50% binding), the effect of 100 µ 
lasted for almost 4 days (Fig. 4). Attempts to reduce the antiserum dose further and titrate the
circulating values to reach a minimum of 20% of binding by 24 h was not successful. Therefore, in
all the subsequent experiments, a dose of 25 µ per monkey was routinely used.
Effect of injecting minimal dose (25 µ ) ofantiserum during midfollicular phase on ovarian function
Groups of normal cyclic monkeys received a single injection of 25 µ antiserum per monkey on
Day 5 or 6 or 7 of cycle. The effect on serum oestrogen and progesterone profiles as well as cycle
length was monitored. Whenever necessary recourse was taken to laparoscopie examination of
the ovarian surface for evidence of newer follicular growth and ovulation. It is evident from Fig.
5 that the effect was variable depending on the day antiserum was injected. In the normal cyclic
monkey oestrogen concentrations start to rise on Day 6-7 and reach a peak on Day 9 or 10 of the
cycle (Fig. 5a). Injecting antiserum on Day 5 or 6 had little effect on the high oestrogen levels of
Day 9 (Fig. 5b, c): in both groups antiserum injection brought about a transient reduction in
serum oestradiol values within 24 h (Day 5 group: from 220 + 140 on Day 5 to 185 + 130 pg/ml
on Day 6; Day 6 group: from 230 + 65 on Day 6 to 116 + 30pg/ml on Day 1;  < 005). These
follicles, however, appeared to return to full activity as seen by normal oestradiol concentrations
on Day 9 (Control, 610 + 300 pg/ml; Day-5 antiserum group, 630 + 96 pg/ml: Day-6 antiserum
group, 730 + 115 pg/ml). While the serum oestradiol values of the Day 5 group (Fig. 5b) kept
rising beyond Day 9 to reach a peak on Day 11, those of the Day-6 group (Fig. 5c) showed an
initial fall like the controls but then levels subsequently rose to reach a second higher peak by
Day 14. Laparoscopie examinations of the ovarian surface on Days 9 and 14 of a fresh group of 3
monkeys which received antiserum on Day 6 confirmed the suspicion that the dominant follicle
that was seen on the surface of one ovary (usually the left ovary) on Day 9 had disappeared on
Day 14 and there was no evidence of corpus luteum formation. In the contralateral ovary, how¬
ever, on Day 14 there was a new dominant follicle which ultimately ovulated and formed a corpus
luteum.
From the serum oestrogen profiles it can be observed that the follicles of the Day-7 treatment
group were most sensitive to the lack of FSH (Fig. 5d). Within 24 h of injection of antiserum, the
oestrogen values dropped from a preinjection value of 360 + 100 to 100 ± 20 pg/ml (P < 005).
The oestrogen values of control animals within the same period increased from 346 + 160 to
540 + 150 pg/ml. The Day-7 follicle did not recover from the 24-h FSH deprivation effect and
a new follicle developed for ovulation, an oestrogen surge being seen on Day 16 of the
cycle. The new follicle apparently ovulated normally as judged by the rise in progesterone
concentrations.
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Fig 3. Effect of administering different doses of FSH antiserum (arrows) on Day 1 of the cycle
upon follicular maturation and corpus luteum function (serum oestrogen and progesterone
profiles), (a) Control monkey pattern (N = 3); (b) monkeys (Nos 76 & 90) injected with 4 ml
antiserum; (c) monkey (No. 66) injected with 1 ml antiserum; (d) monkeys (Nos 76, 90 & 66)
injected with 0-2 ml antiserum.  , Duration of menses.
Effect of FSH antiserum injection during the late follicular phase upon ovarian function
The antiserum was ineffective in influencing steroidogenesis when administered on any day
between Days 9 and 12 of the cycle (Table 2). However, there was a marginal 25% reduction(statistically not significant) of Day-9 oestrogen concentrations when given on Day 8 of the cycle(from a control value of 540 + 150 to 406 + 75 pg/ml). The control animals at the same time
showed an increase in oestrogen values from 540 + 150 to 610 + 300 pg/ml. Antiserum injection
during the late follicular phase had no effect on ovulation or luteal function (Table 2).
Discussion
The follicular maturation process of the primate can be categorized into three phases, an early
phase (Days 1-4) involving recruitment and initiation of growth of a cohort of follicles, a mid-
follicular phase (Days 5-7) involving selection of the follicle which achieves dominance and initia¬
tion of active steroidogenesis, followed by a late follicular phase (Days 8-11) when a spurt in the
growth of the dominant follicle occurs to take it to an ovulable state. The completion in follicular
Table 2. Effect of neutralizing FSH on different days upon ovarian function
Group
Day of cycle
when antiserum
was injected*
No. of
monkeys
Effect on
oestrogen cone.
on Day 9 of
eyelet
Day on which
oestrogen surge
occurred
Length of
luteal phase(days)î
5
6
7
S
9
IO
12
None
None
Reduced by 80%
Reduced by 25%
None
None
None
11
9 and 14
16
9
9
9
9
190 ± 0-8
15-0 ± 1 OH
121 ± 11§
19-5 ± 1-3
170 ± 0-8
19-3 ± 0-9
19-5 + 11
*Except for those in Groups 6 and 7, which received 50 pi per monkey, all animals received 25 pi
antiserum i.p. on the specified day.
tNormal oestrogen concentration on Day 9 = 400 + 140 pg/ml.ÍDays (mean + s.d.) from oestrogen peak to next menses.(¡Length of luteal phase was significantly shortened compared to controls (180 ± 2-2 days);  < 005.
^Calculated from Day 14 oestrogen surge.
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Fig. 4. Binding of 125I-labelled human FSH to antibodies in the circulation in monkeys injected(arrow) with 25 µ (O) or 100 µ (·) FSH antiserum.
growth can perhaps be attested by the occurrence of oestrogen surge and in control bonnet
monkeys this occurs on Day 9 or 10 of the cycle.
In the current study, an attempt has been made to deprive adult cyclic monkeys of FSH support
during the three different phases of follicular growth. The antiserum used specifically neutralizes
primate FSH and, as shown by in-vitro binding (current study) and in-vivo neutralization studies,
has no effect on primate LH activity (Ravindranath, 1988). The overall effect the antiserum pro¬
duces is directly linked to the dose as well as the time of administration, and the capacity of the
antiserum injected at any given time was sufficiently large to neutralize the existing FSH concen¬
trations ofthat day. In the bonnet monkey the FSH concentrations between Days 5 and 7 of cycle
ranged between 2 and 7 ng hFSH equivalent/ml and the surge levels at Days 10-11 ranged between
12 and 18 ng/ml (Ramasharma et al, 1978). After neutralization of FSH from Day 1 of the cycle,
the initiation of the follicular maturation process was arrested. The postponement in the initiation
was linked to the dose of antiserum injected, i.e. the larger the dose the greater the postponement.
The 20% binding level chosen in the current study as the termination of the FSH antibody effect is
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Fig. 5. Effect of injecting (arrow) 25 µ FSH antiserum on Day 5, 6 or 7 of cycle on serum
steroid profiles during the cycle, (a) Serum oestrogen and progesterone profiles in control mon¬
keys (N = 3); (b) Day 5 antiserum treatment group (N = 4); (c) Day 6 antiserum treatment
group (N = 3); (d) Day 7 antiserum treatment group (N = 9).
arbitrary and was considered to coincide in most cases with the starting point of follicular activity,
which was inferred by retrospectively deducting 9 days from the day of the oestrogen surge
(observed) to obtain the start of the follicular activity. This would suggest that, as long as FSH
levels are kept below a threshold, oestrogen production and follicular growth are kept in abeyance
and the 20% binding level referred to above perhaps indicates the turning point when follicular
activity is reinitiated. It would have been prudent to determine circulating FSH concentrations at
this time but the available methodology does not permit us to estimate free FSH in the presence of
antibody. A direct consequence of the reduced FSH and hence oestrogen concentrations is the
lengthening of the follicular phase leading to extension of cycle length. Zeleznik (1981), using
Silastic implants of oestrogen to affect feed back inhibition of FSH secretion, has also observed an
extension of cycle length. In our study, the effect of 0-2 ml FSH antiserum given as a single injection
on Day 1 lasted up to 8 days (based on the time taken for hFSH antibody level to fall to the 20%
binding limit). The follicular activity in this group began by Day 7-8 as indicated by the increase of
oestrogen values, the surge of oestrogen itself occurring 8-9 days later (Fig. 3). Crude pig follicular
fluid, a source of inhibin, has also been used by Stouffer & Hodgen (1980) to reduce FSH values by
40% during Days 1-3 of cycle in rhesus monkeys and this led to a reduction in oestrogen secretion
during the follicular phase followed by a luteal defect.
The current study shows that follicles between Days 5 and 7 become increasingly sensitive to
FSH deprivation, the Day-7 follicle showing maximal sensitivity to the lack of FSH. The follicles of
Days 5 and 6 of cycle show an immediate reduction in oestrogen output after antiserum injection
(based on serum oestrogen levels 24 h later) and regain their ability to produce oestrogen in normal
quantities by Day 9 of the cycle. From the binding data after a 25 µ antiserum injection one would
assume that 24 h later there is still considerable amount of FSH inhibitory activity (50% binding).
However, this appears not to be correct if the efficacy of the antibody is assessed by noting the
period it takes for oestrogen production to restart. Serum FSH concentrations between Days 5 and
7 do not significantly alter and the capacity of the antibody is more than adequate to neutralize
FSH production for 1 day. The current studies therefore suggest that it is better to use return of
steroidogenic response as an end point of antibody efficacy rather than % binding to 125I-labelled
hFSH.
From the serum oestradiol patterns of monkeys treated with antiserum on Day 5, it can be
inferred that either ovulation is postponed by 2 days (as day of oestrogen surge is shifted from Day
9 to 11) or that the dominant follicle ovulâtes in response to normal oestrogen levels on Day 9 and
the increase in oestrogen values seen up to Day 11 is due to secondary follicular activity. The
second possibility, however, seems highly unlikely. Laparoscopie examination of the ovarian
surface on Days 9 and 14 as well as serum progesterone concentrations of monkeys receiving
antiserum on Day 6 indicated that the first dominant follicle in the Day-6 group did not ovulate
despite producing normal levels of oestrogen on Day 9. The oestrogen levels would normally have
signalled the midcycle surge of FSH and LH (not measured). This suggests that the follicle of Day 6
is sensitive to lack of FSH in more than one way. It is possible that the reduction in oestrogen
output between Days 6 and 7 brought about by antiserum injection on Day 6 or the absense of FSH
per se must have initiated other metabolic changes in the Day 6 follicle leading to follicular atresia.
It appears as though this process, once started on Day 6, cannot be reversed by a resumption in the
follicular ability to synthesize oestrogen. The nature of these changes remains to be elucidated. It is
also not clear whether the reduction in oestrogen concentrations between Days 6 and 7 is adequate
to act as a positive feedback effect on FSH release leading to initiation of fresh follicular matu¬
ration and ovulation beyond Day 14. The reason for obtaining significantly higher levels of oestro¬
gen in the Day 5 (on Day 11,  < 005) and Day 6 (on Day 14,  < 001) groups over the control
Day-9 levels is currently not clear. These high concentrations of oestrogen, however, do not lead to
a situation similar to the polycystic ovary syndrome as the oestrogen values return to normal within
24-48 h of the surge. The oestrogen/progesterone secretory pattern in the Day-6 group was sugges¬
tive of a new follicle growing towards maturation. Similar observations were made by Zeleznik et
al (1985), i.e. administration of oestradiol antibodies from Days 5 to 10 of the cycle in cynomolgus
monkeys leads to recruitment of newer follicles to mature. The recovery in the ability of the Day-6
follicle to produce oestradiol could indicate that the follicle has, by this time, developed enough LH
receptors to respond to LH in the absence of FSH (Hillier et al, 1981,1983), but this is belied by the
fact that the Day-7 follicle totally succumbs to the lack of FSH for 24 h and does not recover
preovulatory status or oestrogen synthesizing ability by Day 9. Once again, the observation that
the follicle from Day 8 onwards becomes less sensitive to the lack of FSH suggests that between
Days 6 and 8 some differential changes must be occurring in the follicle making it transform from
an FSH-dependent to a mostly independent state. It could at this time point become totally LH
dependent. Zeleznik & Kubik (1986) have shown that, after initiation of follicular growth by
elevated FSH concentrations, these follicles can continue to mature in the presence of an FSH
concentration which by itself is unable to support the growth of less mature follicles. The LH
concentrations of these monkeys, however, were unaltered, suggesting that LH may have an im¬
portant role once follicular dominance is achieved. If follicular dominance can then be redefined as
that state when the follicle by virtue of developmental changes becomes mostly independent of
FSH support, it can be observed that this is acquired by Day 8 of the cycle. In support of this,
recent studies by Harlow et al (1988) demonstrate that granulosa cell steroidogenesis is highly
sensitive to hFSH during preovulatory follicular development in marmosets. However, in granu¬
losa cells isolated from large preovulatory follicles, androgen suppressed hFSH-stimulated aroma¬
tase activity suggesting a development-dependent change to FSH responsiveness.
In conclusion, the current study shows that initiation of the cyclic follicular maturation process
is dependent on the presence of FSH and the requirement for FSH is confined to the first 7 days of
the total 9-10 days the follicle takes to reach the ovulable state. In particular, a critical need for
FSH appears to be felt when follicular growth has reached the stage seen on Days 6-7 of the cycle
and this could be the signal for asserting follicular dominance.
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